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Introduction
Lung transplant recipients require frequent monitoring
for post-operative complications by multiple noninvasive
and invasive diagnostic tests. They frequently undergo
echocardiography, chest computed tomographic angiog-
raphy (CTA), nuclear medicine lung perfusion imaging
(LPI) and right heart catheterization (RHC).
Purpose
Evaluation of a single comprehensive CMR examination
for identification of post-operative complications.
Methods
We enrolled 16 consecutive lung transplant recipients
who were referred for CMR evaluation at The Methodist
DeBakey Heart & Vascular Center (The Methodist Hospi-
tal, Houston, TX). Eight subjects were men and eight
women; mean age 59.1 ± 9.2 years, 12 Caucasians, 2 His-
panic, 1 African American and 1 Asian. Six subjects had
underlying restrictive (IPF), five had obstructive (COPD/
Emphysema/Cystic fibrosis), and three had other (BOOP/
hypersensitivity pneumonitis) disorders. Nine subjects
had undergone double lung transplant while 7 subjects
had single lung transplant, a mean of 17.9 ± 18.8 months
prior to undergoing CMR imaging. The CMR protocol
included complete short and long axis cine imaging using
SSFP pulse sequences, spin echo imaging to assess pericar-
dial thickness, contrast enhanced MRA of the pulmonary
arterial and venous systems, phase contrast velocity flow
mapping [for main, right and left pulmonary artery (PA)
flows, and PA anastomotic site peak velocities]. All sub-
jects underwent echocardiography, chest CTA, LPI and
RHC as deemed necessary by their transplant pulmonolo-
gist. The records of all diagnostic tests were reviewed and
compared with CMR findings.
Results
All 16 subjects completed CMR imaging without diffi-
culty; no subjects were excluded for reasons of image qual-
ity. Mean scan duration was 76 ± 48 min. The mean LVEF
was 70.6 ± 4.4%; RVEF was 58.8 ± 7.8%, main PA flow
was 5.42 ± 0.99 liter/min, with flows in the transplanted
lung PA 3.0 ± 0.84 liter/min. Of the 16 subjects enrolled,
8 were found to have abnormalities on CMR scanning.
Five subjects demonstrated mild stenosis (less than 40%)
at the transplant-lung PA anastomotic site. One subject
demonstrated severe stenosis (70%) at the PA anasto-
motic site and mild stenosis (33%) at the PV anastomotic
site; these abnormalities were confirmed by RHC and
intravascular ultrasound and the subject therefore under-
went percutaneous PA stenting. Two subjects were found
to have constrictive pericarditis by CMR (detected by chest
CT scan in only one patient); and both were confirmed at
the time of surgical pericardiectomy. No post-operative
complications were detected on any diagnostic tests in the
8 subjects whose CMR demonstrated no complications.
Conclusion
A comprehensive CMR protocol can be a useful single
noninvasive test for the detection of complications after
lung transplantation.
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